Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS | MicrobiomeTrials← Back to trialsNCT05814432
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-01-16Est. Completion: 2032-07-01
Enrollment target: 279 participants Locations- Hospital de Doenças Tropicais, Goiânia, Goiás, Brazil
- Hospital Giselda Trigueiro, Natal, Rio Grande do Norte, Brazil
- Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
- Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Geral de Roraima, Boa Vista, Roraima, Brazil
Other microbiome trials you might be interested in
Acquired Immunodeficiency SyndromeHistoplasmosis AIDSTuberculosis InfectionCryptococcal Meningitis
In Mexico City, the main cause of mortality among people living with HIV (PLHIV) continues to be opportunistic infection…
Mexico City, MexicoCompleted Mar 30, 2024
TuberculosisHIVHistoplasmosis
Tuberculosis (TB) is one opportunistic infection often seen in HIV individuals. In 2013, there were an estimated 31,800 …
Multiple LocationsCompleted Aug 2018
Diego R Falci, MD PhD